Table 2 AGREE II domain score and ICC score of included guidelines
From: Quality assessment of the guidelines for the management of malignant pleural effusions and ascites
Guideline ID | Scope and purpose | Stakeholder involvement | Rigor of development | Clarity and presentation | Applicability | Editorial independence | Overall assessment | |
|---|---|---|---|---|---|---|---|---|
ATS, 2018 [5] | 91.7% | 48.6% | 54.7% | 94.4% | 62.5% | 45.8% | 64.1% | R |
ERS, 2018 [2] | 84.7% | 62.5% | 75.0% | 79.2% | 41.7% | 50.0% | 63.7% | R |
BTS, 2010 [3] | 50.0% | 36.1% | 33.3% | 93.1% | 41.7% | 47.9% | 47.1% | RM |
CGDTMPE, 2014 [4] | 54.2% | 30.6% | 26.0% | 88.9% | 25.0% | 0.0% | 34.5% | RM |
CSCO, 2018 [1] | 69.4% | 47.2% | 41.1% | 91.7% | 42.7% | 0.0% | 47.0% | RM |
CTS, 2009 [6] | 66.7% | 58.3% | 29.7% | 93.1% | 36.5% | 0.0% | 43.8% | RM |
JSPM1, 2016 [7] | 88.9% | 33.3% | 69.8% | 88.9% | 24.0% | 52.1% | 56.3% | RM |
JSPM2, 2016 [8] | 94.4% | 66.7% | 71.4% | 88.9% | 24.0% | 47.9% | 61.1% | R |
JSPM, 2019 [9] | 90.3% | 41.7% | 85.4% | 94.4% | 25.0% | 47.9% | 61.9% | R |
ICC (mean ± SD) | 0.94 ± 0.08 | 0.99 ± 0.008 | 0.98 ± 0.01 | 0.88 ± 0.08 | 0.99 ± 0.01 | 0.99 ± 0.002 | — | — |
Median score (range) | 88.9% (50.0~94.4%) | 47.2% (30.6~66.7%) | 54.7% (26.0~85.4%) | 91.7% (79.2~94.4%) | 36.5% (24.0~62.5%) | 47.9% (0~52.1%) | — | — |